This web publication constitutes a notice for the purposes of regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZX, this notice publishes:
- the decisions made by a delegate1 of the Secretary of the Department of Health and Aged Care (the Delegate) pursuant to regulations 42ZCZU.
- the reasons for the final decisions and
- the date of effect of those decisions.
Defined terms
In this notice the following defined terms are used in addition to those above:
- the Therapeutic Goods Act, 1989 (Cth) (the Act)
- the Scheduling Policy Framework 2018 (the SPF)
- the Scheduling handbook, Guidance for amending the Poisons Standard (the Handbook) and
- the Therapeutic Goods Administration (the TGA).
Note: additional terms are also defined for individual decisions.
Final decisions and reasons
Contents
- Notice of final decisions to amend (or not amend) the current Poisons Standard
- Final decisions on proposed amendments to the current Poisons Standard under regulation 42ZCZU
- Final decision in relation to Bacillus paralicheniformis
- Final decision in relation to dimethyl disulfide
- Final decision in relation to enflicoxib sodium
- Final decision in relation to spidoxamat
For the purposes of s 52D of the Therapeutic Goods Act 1989 (Cth).